| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | CA2352392C Eletriptan hydrobromide monohydrate |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/17/2006 | US6987093 Single dose azithromycin |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614426A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 01/05/2006 | US20060002961 Immunogens; Streptococcus pneumoniae polysaccharide-protein conjugate/antigen, and adjuvant which induces (cytotoxic T) lymphocytes |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714791A Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 12/29/2005 | US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 12/28/2005 | EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 12/28/2005 | EP1609478A1 Exendin agonist peptide formulations |
| 12/28/2005 | EP1401502B1 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer |
| 12/28/2005 | CN1714101A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells. |
| 12/28/2005 | CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy. |
| 12/22/2005 | US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 12/21/2005 | EP1450834B1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 12/20/2005 | US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 12/14/2005 | EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/14/2005 | EP1603887A1 Hiv replication inhibiting pyrimidines and triazines |
| 12/14/2005 | CN1708468A Novel compounds, their preparation and use |
| 12/14/2005 | CN1708293A S1p receptor agonist for treating demyelinate disease |
| 12/13/2005 | US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents; |
| 12/07/2005 | CN1705740A Adenovirus expressing genes in reverse order and use thereof |
| 12/07/2005 | CN1704423A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 12/07/2005 | CN1230170C Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 12/07/2005 | CN1230159C Essential fatty acids in prevention of cardiovascular events |
| 12/01/2005 | US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 12/01/2005 | US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 11/30/2005 | EP1599227A2 Methods of immunomodulation in animals |
| 11/30/2005 | CN1703399A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 11/30/2005 | CN1703237A Treatment of allergic conditions by use of il 21 |
| 11/30/2005 | CN1703232A Method of treating diabetes using plant argyrolobium roseum extract |
| 11/30/2005 | CN1703205A Extended, controlled-release pharmaceutical compositions using charged polymers |
| 11/30/2005 | CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 11/30/2005 | CN1229112C Rapid onset preparation |
| 11/29/2005 | US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 11/29/2005 | US6969721 Tricyclic 2-pyridone compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to |
| 11/24/2005 | US20050261629 Method for delivery of therapeutic and/or diagnostic agents |
| 11/24/2005 | US20050261338 Beta2-adrenergic receptor agonists |
| 11/24/2005 | US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 11/23/2005 | EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 11/23/2005 | EP1597260A1 Triazole compounds useful in therapy |
| 11/23/2005 | EP1597238A1 Hiv replication inhibiting pyrimidines and triazines |
| 11/23/2005 | EP1140291B1 Combination chemotherapy comprising a mitotic inhibitor and a mek inhibitor |
| 11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
| 11/23/2005 | CN1701072A Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 11/23/2005 | CN1701068A Novel compounds and their use |
| 11/23/2005 | CN1699363A Vla-4 inhibitors |
| 11/23/2005 | CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 11/23/2005 | CN1698603A Pharmaceutical composition |
| 11/22/2005 | US6967091 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier |
| 11/22/2005 | CA2249336C Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 11/17/2005 | WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 11/17/2005 | US20050256456 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 11/16/2005 | CN1697661A Methods of treating diabetes using PDE 11A inhibitors |
| 11/16/2005 | CN1227250C Process for preparing azacycloalkanoyl aminothiazoles |
| 11/16/2005 | CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis |
| 11/16/2005 | CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 11/10/2005 | US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 11/10/2005 | US20050250806 Nicotinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
| 11/10/2005 | US20050250802 Novel substituted amines of spirofuropyridines useful in therapy |
| 11/10/2005 | US20050250712 Single dose azithromycin |
| 11/10/2005 | US20050249831 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 11/09/2005 | EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 11/09/2005 | EP1165576B1 Process for preparing amine platinum complexes |
| 11/09/2005 | CN1694866A 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 11/09/2005 | CN1694723A Vaccine |
| 11/08/2005 | US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3 |
| 11/03/2005 | US20050245592 2-Iminopyrrolidine derivatives |
| 11/03/2005 | US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents |
| 11/03/2005 | US20050245565 Diamine derivatives |
| 11/03/2005 | US20050244358 Use of mixture of sodium hyaluronate and chondroitin sulfate for use in products and therapies for cosmetic surgery |
| 11/02/2005 | CN1692101A 4-oxoquinoline compounds and utilization thereof as HIV integrase inhibitors |
| 10/27/2005 | US20050239819 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 10/26/2005 | EP1397133B1 Rapid onset formulation |
| 10/26/2005 | CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 10/26/2005 | CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 10/26/2005 | CN1224612C Acetylenic sulfonamide thiol TACE inhibitors |
| 10/19/2005 | EP1250138B1 Fulvestrant formulation |
| 10/19/2005 | EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 10/19/2005 | CN1223350C Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive |
| 10/18/2005 | US6956060 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 10/12/2005 | CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives |
| 10/12/2005 | CN1679559A Cancer treatment |
| 10/12/2005 | CN1222292C Fulvestrant formulation |
| 10/11/2005 | US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 10/06/2005 | US20050222261 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations |
| 09/28/2005 | CN1674936A Treatment of MS with goat serum |
| 09/28/2005 | CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 09/27/2005 | US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 09/27/2005 | US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 09/27/2005 | US6949525 In particular the treatment of osteochondral lesions associated with osteoarthritis by means of intraarticular application of a mixture of hyaluronate and chondroitin sulfate |
| 09/22/2005 | US20050209128 Statins, especially (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid, as nerve conduction velocity or nerve blood flow enhancers in combination with an aldose reductase inhibitor, an ACE inhibitor or an Angiotensin II antagonist |
| 09/22/2005 | US20050208128 Immediate release tablet |
| 09/21/2005 | EP1575576A2 Organic compounds |